Written answers

Tuesday, 28 November 2017

Department of Health

Medicinal Products Reimbursement

Photo of Billy KelleherBilly Kelleher (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

323. To ask the Minister for Health the outcome of the meeting between a company (details supplied) and the HSE in recent days regarding the drug Vimizim for the treatment of Morquio disease; and if he will make a statement on the matter. [49906/17]

Photo of Kathleen FunchionKathleen Funchion (Carlow-Kilkenny, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

398. To ask the Minister for Health if the HSE drugs committee group met on 14 September 2017; if the drug Vimizim was discussed; if a decision was made to reimburse the drug; and if he will make a statement on the matter. [50276/17]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 323 and 398 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.